The current status of invasive pneumococcal disease in Poland

被引:33
作者
Skoczynska, Anna [1 ]
Sadowy, Ewa [2 ]
Bojarska, Katarzyna
Strzelecki, Janusz
Kuch, Alicja [1 ]
Golebiewska, Agnieszka [1 ]
Wasko, Izabela [1 ]
Forys, Malgorzata [1 ]
van der Linden, Mark [3 ]
Hryniewicz, Waleria [1 ]
机构
[1] Natl Reference Ctr Bacterial Meningitis, Natl Med Inst, Dept Epidemiol & Clin Microbiol, PL-00725 Warsaw, Poland
[2] Natl Med Inst, Dept Mol Microbiol, Warsaw, Poland
[3] Univ Hosp, Natl Reference Ctr Streptococci, Aachen, Germany
关键词
Invasive pneumococcal disease; Streptococcus pneumoniae; Serotype; STREPTOCOCCUS-PNEUMONIAE SEROTYPES; CONJUGATE VACCINE PCV7; ANTIBIOTIC-RESISTANCE; CHILDREN; DECLINE; SUSCEPTIBILITY; EPIDEMIOLOGY; MENINGITIS; IMPACT; ADULTS;
D O I
10.1016/j.vaccine.2010.09.100
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The objectives of this study were to assess the incidence of invasive pneumococcal disease (IPD) in Poland (2006-2009), where mass vaccination had not been implemented, and to determine the serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae isolates. The IPD incidence rates were highest among children under 2 years of age (3.39/100,000 in 2009) and children 2-5 years old (2.44/100,000). The most common serotypes were 14, 3, 1, 4, 19F, 23F, 6B, and 12F (61.7% of all isolates). In children aged less than 5 years, isolates of serotypes 14, 68, and 19F were most prevalent (52.7% of the IPD cases). The PCV7, PCV10, and PCVI3 covered 43.3%, 54.8%, and 68.8% of all IPD cases, and 68.7%, 76.3%, and 86.3% of cases involving children under 5 years of age. Penicillin resistance was found in 21.3% of the isolates responsible for meningitis and in 1.2% of isolates responsible for other invasive infections. Introduction of antipneumococcal conjugated vaccines into the national immunisation programme would likely lead to a significant reduction of IPD-associated morbidity among Polish children in particular, as well as in the population as a whole, especially in cases involving pneumococci with a decreased susceptibility to antibiotics. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2199 / 2205
页数:7
相关论文
共 39 条
[1]   STREPTOCOCCUS-PNEUMONIAE - VIRULENCE FACTORS, PATHOGENESIS, AND VACCINES [J].
ALONSODEVELASCO, E ;
VERHEUL, AFM ;
VERHOEF, J ;
SNIPPE, H .
MICROBIOLOGICAL REVIEWS, 1995, 59 (04) :591-&
[2]  
[Anonymous], 2000, MMWR Recomm Rep, V49, P1
[3]   Resistance among Streptococcus pneumoniae:: Implications for drug selection [J].
Appelbaum, PC .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (12) :1613-1620
[4]   Invasive pneumococcal disease among children in a health district of Barcelona:: early impact of pneumococcal conjugate vaccine [J].
Calbo, E. ;
Diaz, A. ;
Canadell, E. ;
Fabrega, J. ;
Uriz, S. ;
Xercavins, M. ;
Morera, M. A. ;
Cuchi, E. ;
Rodriguez-Carballeira, M. ;
Garau, J. .
CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 (09) :867-872
[5]   Serotype and antibiotic resistance of isolates from patients with invasive pneumococcal disease in Japan [J].
Chiba, N. ;
Morozumi, M. ;
Sunaoshi, K. ;
Takahashi, S. ;
Takano, M. ;
Komori, T. ;
Sunakawa, K. ;
Ubukata, K. .
EPIDEMIOLOGY AND INFECTION, 2010, 138 (01) :61-68
[6]   Streptococcus pneumoniae serotype 19A in children, South Korea [J].
Choi, Eun Hwa ;
Kim, So Hee ;
Eun, Byung Wook ;
Kim, Sun Jung ;
Kim, Nam Hee ;
Lee, Jina ;
Lee, Hoan Jong .
EMERGING INFECTIOUS DISEASES, 2008, 14 (02) :275-281
[7]  
*CLIN LAB STAND I, 2010, M100S20 CLIN LAB STA
[8]   Impact of conjugate pneumococcal vaccines on antibiotic resistance [J].
Dagan, Ron ;
Klugman, Keith P. .
LANCET INFECTIOUS DISEASES, 2008, 8 (12) :785-795
[9]  
Dinleyici EC, 2009, EXPERT REV VACCINES, V8, P977, DOI [10.1586/erv.09.68, 10.1586/ERV.09.68]
[10]   Efficacy of a pneumococcal conjugate vaccine against acute otitis media [J].
Eskola, J ;
Kilpi, T ;
Palmu, A ;
Jokinen, J ;
Haapakoski, J ;
Herva, E ;
Takala, A ;
Käyhty, H ;
Karma, P ;
Kohberger, R ;
Siber, G ;
Mäkela, PH ;
Lockhart, S ;
Ecrola, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (06) :403-409